New oral formulation for 5-HT4 agonists or antagonists

Details for Australian Patent Application No. 2003248212 (hide)

Owner Novartis AG

Inventors Zuger, Othmar; Thewissen, Michael; Engel, Gunter; Vitzling, Christian; Pfannkuche, Hans-Jurgen; De Bruijn, Karel

Agent Davies Collison Cave

Pub. Number AU-A-2003248212

Parent 762829

Filing date 22 September 2003

Wipo publication date 30 October 2003

International Classifications

A61K 009/00 Medicinal preparations characterised by special physical form

Event Publications

9 October 2003 Complete Application Filed

30 October 2003 Application Open to Public Inspection

  Published as AU-A-2003248212

16 February 2006 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003248213-Compositions and methods for therapy and diagnosis of prostate cancer

2003248211-A Crab Holder